BaÑez, Romel A.
HRN: 25-68-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2024
CO-AMOXICLAV 625MG (TAB)
08/22/2024
08/29/2024
PO
625
Q8
Pneumonia
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes